BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang H, He C, Guo X, Fang Y, Lai Q, Wang X, Pan X, Li H, Qin K, Li A, Liu S, Li Q. DDX39B contributes to the proliferation of colorectal cancer through direct binding to CDK6/CCND1. Cell Death Discov 2022;8. [DOI: 10.1038/s41420-022-00827-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Bian Y, Wang Y, Xu S, Gao Z, Li C, Fan Z, Ding J, Wang K. m6A Modification of Long Non-Coding RNA HNF1A-AS1 Facilitates Cell Cycle Progression in Colorectal Cancer via IGF2BP2-Mediated CCND1 mRNA Stabilization. Cells 2022;11:3008. [DOI: 10.3390/cells11193008] [Reference Citation Analysis]
2 Tu Q, Liu X, Yao X, Li R, Liu G, Jiang H, Li K, Chen Q, Huang X, Chang Q, Xu G, Zhu H, Shi P, Zhao B. RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res 2022;41:274. [DOI: 10.1186/s13046-022-02490-3] [Reference Citation Analysis]
3 Ren X, Zhang Q, Guo W, Wang L, Wu T, Zhang W, Liu M, Kong D. Cell-cycle and apoptosis related and proteomics-based signaling pathways of human hepatoma Huh-7 cells treated by three currently used multi-RTK inhibitors. Front Pharmacol 2022;13:944893. [DOI: 10.3389/fphar.2022.944893] [Reference Citation Analysis]
4 Zhao G, Yuan H, Li Q, Zhang J, Guo Y, Feng T, Gu R, Ou D, Li S, Li K, Lin P. DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2. Signal Transduct Target Ther 2022;7:275. [PMID: 35973989 DOI: 10.1038/s41392-022-01096-7] [Reference Citation Analysis]